Suppr超能文献

对标注良好的下一代测序数据的分析显示,奥密克戎导致的 SARS-CoV-2 再感染病例不断增加。

Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.

机构信息

Flow Pharma, Inc., Warrensville Heights, OH, USA.

Case Western Reserve University, Cleveland, OH, USA.

出版信息

Commun Biol. 2023 Mar 18;6(1):288. doi: 10.1038/s42003-023-04687-4.

Abstract

SARS-CoV-2 has extensively mutated creating variants of concern (VOC) resulting in global infection surges. The Omicron VOC reinfects individuals exposed to earlier variants of SARS-CoV-2 at a higher frequency than previously seen for non-Omicron VOC. An analysis of the sub-lineages associated with an Omicron primary infection and Omicron reinfection reveals that the incidence of Omicron-Omicron reinfections is occurring over a shorter time interval than seen after a primary infection with a non-Omicron VOC. Our analysis suggests that a single infection from SARS-CoV-2 may not generate the protective immunity required to defend against reinfections from emerging Omicron lineages. This analysis was made possible by Next-generation sequencing (NGS) of a Danish cohort with clinical metadata on both infections occurring in the same individual. We suggest that the continuation of COVID-19 NGS and inclusion of clinical metadata is necessary to ensure effective surveillance of SARS-CoV-2 genomics, assist in treatment and vaccine development, and guide public health recommendations.

摘要

SARS-CoV-2 广泛变异产生了令人关注的变种(VOC),导致了全球感染浪潮。奥密克戎 VOC 比以前非奥密克戎 VOC 更容易重新感染先前接触过 SARS-CoV-2 早期变种的个体。对奥密克戎初次感染和奥密克戎再感染相关亚谱系的分析表明,奥密克戎-Omicron 再感染的发生率比初次感染非奥密克戎 VOC 后的时间间隔更短。我们的分析表明,单次感染 SARS-CoV-2 可能不会产生对抗新兴奥密克戎谱系再感染所需的保护性免疫。这项分析是通过对丹麦队列进行下一代测序(NGS)实现的,该队列具有两次感染的临床元数据,均发生在同一个体中。我们建议继续进行 COVID-19 NGS,并纳入临床元数据,以确保对 SARS-CoV-2 基因组学进行有效监测,协助治疗和疫苗开发,并指导公共卫生建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f4/10024752/3027ebb31572/42003_2023_4687_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验